Glycemic Index, Glycemic Load, and Cardiovascular Disease and Mortality
| Primer Autor |
Jenkins, David J. A.
|
| Título |
Glycemic Index, Glycemic Load, and Cardiovascular Disease and Mortality
|
| Editorial |
MASSACHUSETTS MEDICAL SOC
|
| Revista |
NEW ENGLAND JOURNAL OF MEDICINE
|
| Lenguaje |
en
|
| Tipo de Recurso |
artículo original
|
| Derecho de Acceso |
restringido
|
| Description |
Supported by the Population Health Research Institute, Hamilton Health Sciences Research Institute, the Canadian Institutes of Health Research, Heart and Stroke Foundation of Ontario, Strategy for Patient Oriented Research of the Canadian Institutes of Health Research through the Ontario Strategy for Patient-Oriented Research Support Unit, and the Ontario Ministry of Health and Long-Term Care, by unrestricted grants from several pharmaceutical companies, with major contributions from AstraZeneca (Canada), Sanofi-Aventis (France and Canada), Boehringer Ingelheim (Germany and Canada), Servier, and GlaxoSmithKline, and by additional contributions from Novartis and King Pharma and from various national or local organizations in participating countries as follows: Argentina: Fundacion Estudios Clinicos Latino America, Bangladesh: Independent University, Bangladesh, and Mitra and Associates, Brazil: Unilever Health Institute, Canada: Dairy Farmers of Canada, National Dairy Council of the United States, Public Health Agency of Canada, and Champlain Cardiovascular Disease Prevention Network, Chile: Universidad de La Frontera, China: National Center for Cardiovascular Diseases and ThinkTank Research Center for Health Development, Colombia: Colciencias, India: Indian Council of Medical Research, Malaysia: Ministry of Science, Technology, and Innovation of Malaysia, Ministry of Higher Education of Malaysia, Universiti Teknologi MARA, and Universiti Kebangsaan Malaysia, Palestinian territory: United Nations Relief and Works Agency for Palestine Refugees in the Near East and International Development Research Centre, Canada, Philippines: Philippine Council for Health Research and Development, Poland: Polish Ministry of Science and Higher Education and Wroclaw Medical University, Saudi Arabia: Saudi Heart Association, Dr. Mohammad Alfagih Hospital, Deanship of Scientific Research at King Saud University, Saleh Hamza Serafi Chair for Research of Coronary Heart Disease, and Umm al-Qura University, South Africa: North-West University, Netherlands Programme for Alternative Development, National Research Foundation, Medical Research Council of South Africa, South Africa Sugar Association, and Faculty of Community and Health Sciences, Sweden: Swedish government, Swedish Heart and Lung Foundation, Swedish Research Council, Swedish Council for Health, Working Life, and Welfare, King Gustaf V and Queen Victoria's Foundation of Freemasons, and AFA Insurance, Turkey: Metabolic Syndrome Society, AstraZeneca, and SanofiAventis, and the United Arab Emirates: Sheikh Hamdan Bin Rashid Al Maktoum Award for Medical Sciences and Dubai Health Authority. Dr. Jenkins receives salary support and discretionary funding from the Canada Research Chair endowment of the federal government of Canada. Dr. S. Yusuf is supported by the Marion W. Burke Chair in Cardiovascular Disease of the Heart and Stroke Foundation of Ontario.
|
| doi |
10.1056/NEJMoa2007123
|
| Formato Recurso |
pdf
|
| Ubicación del archivo | |
| Categoría OCDE |
Medicina general e interna
|
| Disciplinas de la OCDE |
Medicina General e Interna
|
| Id de Web of Science |
WOS:000637799800009
|
| Access Rights |
restringido
|
| Derechos de acceso |
restringido
|
| Título de la cita (Recomendado-único) |
Glycemic Index, Glycemic Load, and Cardiovascular Disease and Mortality
|
| Identificador del recurso (Mandatado-único) |
artículo original
|
| Versión del recurso (Recomendado-único) |
version publicada
|
| Editorial |
MASSACHUSETTS MEDICAL SOC
|
| Revista/Libro |
NEW ENGLAND JOURNAL OF MEDICINE
|
| Categoría WOS |
Medicina general e interna
|
| Idioma |
en
|
| ISSN |
0028-4793
|
| Descripción |
Supported by the Population Health Research Institute, Hamilton Health Sciences Research Institute, the Canadian Institutes of Health Research, Heart and Stroke Foundation of Ontario, Strategy for Patient Oriented Research of the Canadian Institutes of Health Research through the Ontario Strategy for Patient-Oriented Research Support Unit, and the Ontario Ministry of Health and Long-Term Care, by unrestricted grants from several pharmaceutical companies, with major contributions from AstraZeneca (Canada), Sanofi-Aventis (France and Canada), Boehringer Ingelheim (Germany and Canada), Servier, and GlaxoSmithKline, and by additional contributions from Novartis and King Pharma and from various national or local organizations in participating countries as follows: Argentina: Fundacion Estudios Clinicos Latino America, Bangladesh: Independent University, Bangladesh, and Mitra and Associates, Brazil: Unilever Health Institute, Canada: Dairy Farmers of Canada, National Dairy Council of the United States, Public Health Agency of Canada, and Champlain Cardiovascular Disease Prevention Network, Chile: Universidad de La Frontera, China: National Center for Cardiovascular Diseases and ThinkTank Research Center for Health Development, Colombia: Colciencias, India: Indian Council of Medical Research, Malaysia: Ministry of Science, Technology, and Innovation of Malaysia, Ministry of Higher Education of Malaysia, Universiti Teknologi MARA, and Universiti Kebangsaan Malaysia, Palestinian territory: United Nations Relief and Works Agency for Palestine Refugees in the Near East and International Development Research Centre, Canada, Philippines: Philippine Council for Health Research and Development, Poland: Polish Ministry of Science and Higher Education and Wroclaw Medical University, Saudi Arabia: Saudi Heart Association, Dr. Mohammad Alfagih Hospital, Deanship of Scientific Research at King Saud University, Saleh Hamza Serafi Chair for Research of Coronary Heart Disease, and Umm al-Qura University, South Africa: North-West University, Netherlands Programme for Alternative Development, National Research Foundation, Medical Research Council of South Africa, South Africa Sugar Association, and Faculty of Community and Health Sciences, Sweden: Swedish government, Swedish Heart and Lung Foundation, Swedish Research Council, Swedish Council for Health, Working Life, and Welfare, King Gustaf V and Queen Victoria's Foundation of Freemasons, and AFA Insurance, Turkey: Metabolic Syndrome Society, AstraZeneca, and SanofiAventis, and the United Arab Emirates: Sheikh Hamdan Bin Rashid Al Maktoum Award for Medical Sciences and Dubai Health Authority. Dr. Jenkins receives salary support and discretionary funding from the Canada Research Chair endowment of the federal government of Canada. Dr. S. Yusuf is supported by the Marion W. Burke Chair in Cardiovascular Disease of the Heart and Stroke Foundation of Ontario.
|
| Referencia del Financiador (Mandatado si es aplicable-repetible) |
PHRI
HHSRI
CIHR
Heart and Stroke
Ontario Ministry of Health and Long-Term Care
AstraZeneca (Canada)
Sanofi-Aventis (France and Canada)
Boehringer Ingelheim (Germany and Canada)
Servier
GlaxoSmithKline
Novartis and King Pharma
Fundacion Estudios Clinicos Latino America
Independent University, Bangladesh, and Mitra and Associates
Unilever Health Institute
Dairy Farmers of Canada, National Dairy Council of the United States, Public Health Agency of Canada, and Champlain Cardiovascular Disease Prevention Network
UFRO
National Center for Cardiovascular Diseases
ThinkTank Research Center for Health Development
ColCiencias
Indian Council of Medical Research
MOSTI
MOHE
Universiti Teknologi MARA
Universiti Kebangsaan Malaysia
Palestinian territory: United Nations Relief and Works Agency for Palestine Refugees in the Near East and International Development Research Centre
Philippine Council for Health Research and Development
Polish Ministry of Science and Higher Education Wroclaw Medical University
Saudi Heart Association Dr. Mohammad Alfagih Hospital, Deanship of Scientific Research at King Saud University, Saleh Hamza Serafi Chair for Research of Coronary Heart Disease, and Umm al-Qura University
North-West University, Netherlands Programme for Alternative Development
National Research Foundation
Medical Research Council of South Africa
South Africa Sugar Association, and Faculty of Community and Health Sciences
Swedish government, Swedish Heart and Lung Foundation
Swedish Research Council
Swedish Council for Health, Working Life, and Welfare
King Gustaf V Queen Victoria's Foundation of Freemasons AFA Insurance
Metabolic Syndrome Society
AstraZeneca
SanofiAventis
Sheikh Hamdan Bin Rashid Al Maktoum Award for Medical Sciences and Dubai Health Authority. Dr. Jenkins
Canada Research ChaiR
|
| Tipo de ruta |
suscripción
|
| Formato |
pdf
|
- Colecciones
- Colección Publicaciones Científicas
cienciaabierta.ufro.cl
ciencia.abierta@ufrontera.cl